Drug delivery to the brain

Journal of Cerebral Blood Flow and Metabolism

Volumn 17, Issue 7, 1997, Pages 713-731

  Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ATENOLOL; CARMUSTINE; CHOLECYSTOKININ; CYTOCHALASIN B; DAUNORUBICIN; EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN P; KAINIC ACID; LEVODOPA; LIPOSOME; MONOCLONAL ANTIBODY; NEUROTROPHIN; OPIATE PEPTIDE; RADIOPHARMACEUTICAL AGENT; RECOMBINANT PROTEIN; SEROTONIN 1 RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

BLOOD BRAIN BARRIER; BRAIN MICROCIRCULATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG IMPLANTATION; DRUG PENETRATION; DRUG SOLUBILITY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRACEREBRAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIPID SOLUBILITY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW;

EID: 0030869483     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199707000-00001     Document Type: Review

References (127)

1. Aird RB (1984) A study of intrathecal, cerebrospinal fluid-to-brain exchange. Exp Neurol 86:342-358
2. Barrand MA, Robertson KJ, von Weikersthal SF (1995) Comparisons of P/glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta. FEBS Lett 374:179-183
3. Baskin DG, Woods SC, West DB, van Houten M, Posner BI, Dorsa DM, Porter Jr. D (1983) Immunocytochemical detection of insulin in rat hypothalamus and its possible uptake from cerebrospinal fluid. Endocrinology 113:1818-1825
4. Bickel U, Yoshikawa T, Landaw EM, Faull KF, Pardridge WM (1993) Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc Natl Acad Sci USA 90:2618-2622
5. Bickel U, Kang Y-S, Yoshikawa T, Pardridge WM (1994) In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate within brain capillary endothelium. J Histochem Cytochem 42:1493-1497
6. Billiau A, Heremans H, Ververken D, Van Damme J, Carton H, de Somer P (1981) Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice. Arch Virol 68:19-25
7. Boado RJ, Pardridge WM (1992) Complete protection of antisense oligonucleotides against serum nuclease degradation by an avidin-biotin system. Bioconj Chem 3:519-523
8. Boado RJ, Pardridge WM (1994) Complete inactivation of target mRNA by biotinylated antisense oligodeoxynucleotide-avidin conjugates. Bioconj Chem 5:406-410
9. Boado RJ, Kang Y-S, Wu D, Pardridge WM (1995) Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond. Drug Metab Dispos 23:1297-1300
10. Bodor N, Farag HH, Brewster III ME (1981) Site-specific, sustained release of drugs to the brain. Science 214:1370-1372
11. Broadwell RD, Balin BJ, Salcman M (1988) Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc Natl Acad Sci USA 85:632-636
12. Broman T (1941) The possibilities of the passage of substances from the blood to the central nervous system. Acta Psych Neurol 16:1-25
13. Chekhonin VP, Kabanov AV, Zhirkov YA, Morozov GV (1991) Fatty acid acylate Fab-fragments of antibodies to neurospecific proteins as carriers for neuroleptic targeted delivery in brain. FEBS Lett 287:149-152
14. Chonn A, Semple SC, Cullis PR (1992) Association of blood proteins with large unilamellar liposomes in vivo. J Biol Chem 267:18759-18765
15. Cordon-Cado C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR (1989) Multi-drug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698
16. Cornford EM, Young D, Paxton JW, Finlay GJ, Wilson WR, Pardridge WM (1992) Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain. Cancer Res 52:138-143
17. Covell DG, Narang PK, Poplack DG (1985) Kinetic model for disposition of 6-mercaptopurine in monkey plasma and cerebrospinal fuid. Am J Physiol 248:R147-R156
18. Crawley JN, Fiske SM, Durieux C, Derrien M, Roques BP (1991) Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism. J Pharmacol Exp Ther 257: 1076-1080
19. Cusack B, McCormick DJ, Pang Y-P, Souder T, Garcia R, Fauq A, Richelson E (1995) Pharmacological and biochemical profiles of unique neurotensin 8-13 analogs exhibiting species selectivity, stereoselectivity, and superagonism. J Biol Chem 270:18359-18366
20. Davson H, Welch K, Segal MB (1987) Secretion of the cerebrospinal fluid. In: The Physiology and Pathophysiology of the Cerebrospinal Fluid, London, Churchill Livingstone, p 201
21. Dehouck B, Dehouck MP, Fruchart JC, Cecchilli R (1994) Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes. J Cell Biol 126:465-473
22. de Lange ECM, Danhof M, de Boer AG, Breimer DD (1994) Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain. Brain Res 666:1-8
23. Dohrmann G (1970) The choroid plexus: a historical review. Brain Res 18:197-218
24. Doran SE, Dan Ren X, Betz AL, Pagel MA, Neuwelt EA, Roessler BJ, Davidson BL (1995) Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurg 36:965-970
25. Duffy KR, Pardridge WM (1987) Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res 420:32-38
26. Duvernoy H, Delon S, Vannson JL (1983) The vascularization of the human cerebellar cortex. Brain Res Bull 11:419-480
27. Eytan GD, Regev R, Oren G, Assaraf YG (1996) The role of passive transbilayer drug movement in multidrug resistance and its modulation. J Biol Chem 271:12897-12902
28. Feigner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Feigner PL (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269:2550-2561
29. Fenstermacher J, Kaye T (1988) Drug "diffusion" within the brain. Ann N Y Acad Sci 531:29-39
30. Ferguson IA, Schweitzer JB, Bartlett PF, Johnson Jr, EM (1991) Receptor-mediated retrograde transport in CNS neurons after intra-ventricular administration of NGF and growth factors. J Comp Neurol 313:680-692
31. Fishman JB, Rubin JB, Handrahan JV, Conner JR, Fine RE (1987) Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res 18:299-304
32. Freese A, Geller AI, Neve R (1990) HSV-1 vector mediated neuronal gene delivery. Biochem Pharmacol 40:2189-2199
33. Friden PM, Walus LR, Watson P, Doctrow SR, Kozarich JW, Backman C, Bergman H, Hoffer B, Blood F, Granholm A-C (1993) Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259:373-377
34. Fung LK, Shin M, Tyler B, Brem H, Saltzman WM (1996) Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Pharm Res 13(5): 671-682
35. Gennuso RG, Spigelman MK, Chinol M, Zappulla RA, Nieves J, Vallabhajosula S, Paciucci A, Goldsmith SJ, Holland JF (1993) Effect of blood-brain barrier and blood-tumor barrier and blood-tumor barrier modification on central nervous system liposomal uptake. Cancer Invest 11:118-128
36. Golden PL, Maccagnan TJ, Pardridge WM (1997) Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest 99:14-18
37. Granholm A-C, Backman C, Bloom F, Ebendal T, Gerhardt GA, Hoffer B, Mackerlova L, Olson L, Soderstrom S, Walus LR, Friden PM (1993) NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants. J Pharm Exp Ther 268:448-459
38. Greenwood J (1990) Mechanisms of blood-brain barrier breakdown. Neurorad 33:95-100
39. Greig NH, Fredericks WR, Holloway HW, Soncrant TT, Rapoport SI (1988) Delivery of human interferon-alpha to brain by transient osmotic blood-brain barrier modification in the rat. J Pharm Exp Ther 245:581-586
40. Greig NH, Soncrant TT, Shetty HU, Momma S, Smith QR, Rapoport SI (1990) Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat. Cancer Chemother Pharmacol 26:263-268
41. 2-Receptors mediate increases in permeability of the blood-brain barrier during arterial histamine infusion. Brain Res 210:396-400
42. Hazel JR, Sidell BD (1987) A method for the determination of diffusion coefficients for small molecules in aqueous solution. Anal Biochem 166:335-341
43. Hefti F, Schneider LS (1991) Nerve growth factor and Alzheimer's disease. Clin Neuropharm 14:S62-S76
44. Herz A, Albus K, Metys J, Schubert P, Teschemacher HJ (1970) On the central sites for the antinociceptive action of morphine and fentanyl. Neuropharmacol 9:539-551
45. Hiesiger EM, Voorhies RM, Basler GA, Lipschutz LE, Posner JB, Shapiro WR (1986) Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow. Ann Neurol 19:50-59
46. Hingson DJ, Diamond JM (1972) Comparison of nonelectrolyte permeability patterns in several epithelia. J Membr Biol 10:93-135
47. Huwyler J, Wu D, Pardridge WM (1996) Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA 93:14, 164-14, 169
48. Huwyler J, Yang J, Pardridge WM (1997) Receptor-mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat. J Pharmacol Exp Ther (in press)
49. Inamura T, Black KL (1994) Bradykinin selectivity opens blood-tumor barrier in experimental brain tumors. J Cereb Blood Flow Metab 14:862-870
50. Jain RK (1990) Tumor physiology and antibody delivery. Front Radiat Ther Oncol 24:32-46
51. Jette L, Tetu B, Beliveau R (1993) High levels of P-glycoprotein detected in isolated brain capillaries. Biochim Biophys Acta 1150: 147-154
52. 32P]labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/ monoclonal antibody conjugate. Drug Metab Dispos 23:55-59
53. Koliatsos VE, Applegate MD, Knusel B, Junard EO, Burton LE, Mobley WC, Hefti FF, Price DL (1991a) Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat. Exp Neurol 112: 161-173
54. Koliatsos VE, Clatterbuck RE, Nauta HJW, Knusel B, Burton LE, Hefti FF, Mobley WC, Price DL (1991b) Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann Neurol 30:831-840
55. Kordower JH, Winn SR, Liu Y-T, Mufson EJ, Sladek JR, Hammang JP, Baetge EE, Emerich DF (1994) The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA 91:10898-10902
56. Krewson CE, Klarman ML, Saltzman WM (1995) Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res 680:196-206
57. Krewson CE, Saltzman WM (1996) Transport and elimination of recombinant human NGF during long-term delivery to the brain. Brain Res 727:169-181
58. Kumagai AK, Eisenberg J, Pardridge WM (1987) Absorptive-mediated endocytosis of cationized albumin and a β-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem 262:15214-15219
59. Le Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M, Mallet J (1993) An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990
60. LeSauteur L, Wei L, Gibbs BF, Saragovi HU (1995) Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J Biol Chem 270:12, 6564-6569
61. Levin VA (1980) Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23:682-684
62. Liu Y, Mounkes LC, Liggitt HD, Brown CS, Solodin I, Heath TD, Debs RJ (1997) Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat Biotechnol 15: 167-173
63. Lossinsky AS, Vorbrodt AW, Wisniewski HM (1995) Scanning and transmission electron microscopic studies of microvascular pathology in the osmotically impaired blood-brain barrier. J Neurocytol 24:795-806
64. Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW (1992) Reversible in vitro growth of Alzheimer disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 89:5462-5466
65. Matsui H, Johnson LG, Randell SH, Boucher RC (1997) Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J Biol Chem 272:1117-1126
66. Mayhan WG, Didion SP (1996) Glutamate-induced disruption of the blood-brain barrier in rats. Role of nitric oxide. Stroke 27:965-970
67. McCulloch J, Edvinsson L (1980) Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide. Am J Physiol 238:H449-H456
68. Nadal A, Fuentes E, Pastor J, McNaughton PA (1995) Plasma albumin is a potent trigger of calcium signals and DNA synthesis in astrocytes. Proc Natl Acad Sci USA 92:1426-1430
69. Nag S (1995) Role of the endothelial cytoskeleton in blood-brain-barrier permeability to protein. Acta Neuropathol 90:454-460
70. Nagy Z, Szabo M, Huttner I (1985) Blood-brain barrier impairment by low pH buffer perfusion via the internal carotid artery in rat. Acta Neuropathol 68:160-163
71. Nakano S, Matsukado K, Black KL (1996) Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 68:4027-4031
72. Neuwelt EA, Rapoport SI (1984) Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed Proc 43:214-219
73. Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsey F, Roman-Goldstein S, Braziel R, Dana B (1991) Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9:1580-1590
74. Nucci ML, Shorr R, Abuchowski A (1991) The therapeutic value of poly(ethylene glycol)-modified proteins. Adv Drug Del Rev 6:133-151
75. Odorizzi G, Pearse A, Domingo D, Trowbridge IS, Hopkins CR (1996) Apical and basolateral endosomes of MDCK cells are interconnected and contain a polarized sorting mechanism. J Cell Biol 135:139-152
76. Ohlstein EH, Nambi P, Douglas SA, Edwards RM, Gellai M, Lago A, Leber JD, Cousins RD, Gao A, Frazee JS, Peishoff CE, Bean JW, Eggleston DS, Elshourbagy NA, Kumar C, Lee JA, Yue T-L, Louden C, Brooks DP, Weinstock J, Feuerstein G, Poste G, Ruffolo RR, Gleason JG, Elliott JD (1994) SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc Natl Acad Sci USA 91:8052-8056
77. 33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. J Pharm Sci 85:612-618
78. 99mTc] PnAO-biotin. Eur J Nucl Med 21:314-321
79. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee K-D, Woodle MC, Lasic DD, Redemann C, Martin FJ (1991) Sterically stabilized liposomes: improvement in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 88:11460-11464
80. Pardridge WM (1991) Peptide Drug Delivery to the Brain. New York, Raven Press, p 1-357
81. Pardridge WM, Kang Y-S, Buciak JL (1994) Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm Res 11:738-746
82. Pardridge WM (1995) Vector-mediated peptide drug delivery to the brain. Adv Drug Del Rev 15:109-146
83. Pardridge WM, Kang Y-S, Buciak JL, Yang J (1995) Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Res 12:807-816
84. Pardridge WM, Boado RJ, Kang Y-S (1995) Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo. Proc Natl Acad Sci USA 92:5592-5596
85. Pardridge WM (1986) Blood-brain barrier. Interface between internal medicine and the brain. Ann Int Med 105:82-95
86. Pardridge WM, Golden PL, Kang Y-S, Bickel U (1997) Brain micro-vascular and astrocyte localization of p-glycoprotein J Neurochem 68:1278-1285
87. Pastan I, Willingham MC, Gottesman M (1991) Molecular manipulations of the multidrug transporter: a new role for transgenic mice FASEB J 5:2523-2528
88. Prigent SA, Stanley KK, Siddle K (1990) Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monocloanal antibodies. J Biol Chem 265:9970-9977
89. Reinhardt RR, Bondy CA (1994) Insulin-like growth factors cross the blood-brain barrier. Endocrinology 135:1753-1761
90. Rosenberg MB, Hawrot E, Breakefield XO (1986) Receptor binding activities of biotinylated derivatives of β-nerve growth factor. J Neurochem 46:641-648
91. 1-40/vector complex. Proc Natl Acad Sci USA 92:10227-10231
92. Sakane T, Pardridge WM (1997) Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity. Pharm Res (in press)
93. Salahuddin TS, Johansson BB, Kalimo H, Olsson Y (1988) Structural changes in the rat brain after carotid infusions of hyperosmolar solutions. An electron microscopic study. Acta Neuropathol 77:5-13
94. Schackert G, Fan D, Nayar R, Fidler IJ (1989) Arrest and retention of multilamellar liposomes in the brain of normal mice or mice bearing experimental brain metastases. Selective Cancer Ther 5:73-79
95. Schinkel AH, Wagenaar E, van Deemter L, Mol CAAM, Borst P (1995) Absence of the mdr1a p-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:1698-1705
96. 2. Prostaglandin Leukotrienes Essential Fatty Acids 47:105-110
97. Seiler M, Schwab ME (1984) Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res 300:33-39
98. Shashoua VE, Hesse GW (1996) N-docosahexaenoyl, 3 hydroxytyramine: a dopaminergic compound that penetrates the blood-brain barrier and suppresses appetite. Life Sci 58:1347-1357
99. Shin S-U, Wu D, Ramanthan R, Pardridge WM, Morrison SL (1997) Functional and pharmacokinetic properties of antibody/avidin fusion proteins. J Jmmunol 158:4797-4804
100. Spigelman MK, Zappulla RA, Goldberg JD, Goldsmith SJ, Marotta D, Malis LI, Holland JF (1984) Effect of intracarotid etoposide on opening the blood-brain barrier. Cancer Drug Del 1:3207-3211
101. Stein CA, Cheng Y-C (1993) Antisense oligonucleotides as therapeutic agents - is the bullet really magical. Science 261:1004-1011
102. Stewart PA, Beliveau R, Rogers K (1996) Cellular localization of p-glycoprotein in brain versus gonadal capillaries. J Histochem Cytochem 44:679-685
103. Suhr ST, Gage FH (1993) Gene therapy for neurologic disease. Arch Neurol 50:1252-1268
104. Swindler DR, Erwin J (eds) (1986) Comparative Primate Biology. Vol 1 (Systematics, Evolution, and Anatomy). New York, Alan R. Liss, Inc
105. Sztriha L, Betz AL (1991) Oleic acid reversibly opens the blood-brain barrier. Brain Res 550:257-262
106. Suzuki Y, McMaster D, Lederis K, Rorstad OP (1984) Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and PHI on isolated brain arteries. Brain Res 322:9-16
107. Tokes ZA, St Peteri AK, Todd JA (1980) Availability of liposome content to the nervous system. Liposomes and the blood-brain barrier. Brain Res 188:282-286
108. Trauble H (1971) The movement of molecules across lipid membranes: a molecular theory. J Membr Biol 4:193-208
109. Triguero D, Buciak JB, Pardridge WM (1990) Capillary depletion method for quantifying blood-brain barrier transcytosis of circulating peptides and plasma proteins. J Neurochem 54:1882-1888
110. 2]leuenkephalin derivatives conjugated with the 1-adamantane moiety. Biochem Pharmacol 41:R5-R8
111. Tsuzuki N, Hama T, Kawada M, Hasui A, Konishi R, Shiwa S, Ochi Y, Futaki S, Kitagawa K (1994) Adamantane as a brain-directed drug carrier for poorly absorbed drug. 2. AZT derivatives conjugated with the 1-adamantane moiety. J Pharmaceut Sci 83:4481-4484
112. Wade LA, Katzman R (1975) Rat brain regional uptake and decarboxylation of L-dopa following carotid injection. Am J Physiol 228: 352-359
113. Walus LR, Pardridge WM, Starzyk RM, Friden PM (1996) Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier following conjugation to anti-transferrin receptor antibodies. J Pharmacol Exp Ther 277:1067-1075
114. Weiner HL (1994) Oral tolerance. Proc Natl Acad Sci USA 91:10762-10765
115. White FP, Dutton GR, Norenberg MD (1981) Microvessels isolated from rat brain: localization of astrocyte processes by immunohistochemical techniques. J Neurochem 36:328-332
116. Whitesell L, Geselowitz D, Chavany C, Fahmy B, Walbridge S, Alger JR, Neckers LM (1993) Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. Proc Natl Acad Sci USA 90:4665-4669
117. Winkler T, Sharma HS, Stalberg E, Olsson Y, Dey PK (1995) Impairment of blood-brain barrier function by serotonin induces desynchronization of spontaneous cerebral cortical activity: experimental observations in the anaesthetized rat. Neurosci 68:1097-1104
118. Wojcik WJ, Swoveland P, Zhang X, Vanguri P (1996) Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of Lewis rat. J Pharmacol Exp Ther 278:404-410
119. Wong FMP, Reimer DL, Bally MB (1996) Cationic lipid binding to DNA: characterization of complex formation. Biochemistry 35: 5756-5763
120. Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ (1996) Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273:458-471
121. 3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system. J Pharmacol Exp Ther 276:206-211
122. Wu D, Pardridge WM (1996) CNS pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analogue coupled to a blood-brain barrier drug delivery system. J Pharmacol Exp Ther 279:77-83
123. Wu D, Yang J, Pardridge WM (1997) Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. J Clin Invest (in press)
124. Xiang T-X, Anderson BD (1994) The relationship between permeant size and permeability in lipid bilayer membranes. J Membr Biol 140:111-122
125. Yakubov L, Khaled Z, Zhang L-M, Truneh A, Vlassov V, Stein CA (1993) Oligodeoxynucleotides interact with recombinant CD4 at multiple sites. J Biol Chem 268:25, 18818-18823
126. Yamada K, Kinoshita A, Kohmura E, Sakaguchi T, Tajuchi J, Kataoka K, Hayakawa T (1991) Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction. J Cereb Blood Flow Metab 11:472-478
127. Yan Q, Matheson C, Sun J, Radeke MJ, Feinstein SC, Miller JA (1994) Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with Trk receptor expression. Exp Neurol 127:23-36